Cytomx Therapeutics, Inc.
CTMX
Revenue
25.12M
▼-16.35M▼-39.43%
3 Months ChangeAssets
159.22M
▼-25.47M▼-13.79%
3 Months ChangeLiabilities
190.45M
▼-25.92M▼-11.98%
3 Months ChangeFree Cash Flow
-26.16M
▼-35.46M▼-381.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 8-K
ID: 0000950170-24-093936
2024-08-08
Form 10-Q
ID: 0000950170-24-093865
2024-06-17
Form 8-K
ID: 0001193125-24-162652
2024-05-17
Form 8-K
ID: 0001193125-24-141699
2024-05-08
Form 8-K
ID: 0001193125-24-134284
2024-05-08
Form 8-K
ID: 0000950170-24-055598
2024-05-08
Form 10-Q
ID: 0000950170-24-055588
2024-03-22
Form 8-K
ID: 0001193125-24-075211
2024-03-11
Form 8-K
ID: 0000950170-24-029207
2023-11-07
Form 8-K
ID: 0000950170-23-060221